+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Eisai Co - logo

Eisai Limited is a research-based pharmaceutical company that develops, manufactures, and markets healthcare products for patients and their families. It offers products in the areas of Alzheimer's disease, gastrointestinal disorders, epilepsy, cervical dystonia, severe chronic pain, and oncology. The company was founded in 1988 and is based in Hatfield, United Kingdom. It also has operations in the United States, Asia, and Europe.

Breast Cancer Drugs Global Market Report 2024 - Product Thumbnail Image

Breast Cancer Drugs Global Market Report 2024

  • Report
  • November 2023
  • 175 Pages
  • Global
From
Insomnia Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update - Product Thumbnail Image

Insomnia Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update

  • Report
  • July 2022
  • 639 Pages
  • Global
From
Distribution Deals in Pharmaceuticals and Biotechnology 2016 to 2024 - Product Thumbnail Image

Distribution Deals in Pharmaceuticals and Biotechnology 2016 to 2024

  • Report
  • September 2024
  • 550 Pages
  • Global
From
Pruritus Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Pruritus Therapeutics - Global Strategic Business Report

  • Report
  • November 2024
  • 192 Pages
  • Global
From
HER2Negative Metastatic Breast Cancer - Pipeline Insight, 2024 - Product Thumbnail Image

HER2Negative Metastatic Breast Cancer - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 180 Pages
  • Global
From
Rare Disease Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa) - Product Thumbnail Image

Rare Disease Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

  • Report
  • January 2024
  • 283 Pages
  • Global
Brain Tumor Drugs Global Market Report 2024 - Product Thumbnail Image

Brain Tumor Drugs Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
HR Positive/ HER2 Negative Breast Cancer - Pipeline Insight, 2024 - Product Thumbnail Image

HR Positive/ HER2 Negative Breast Cancer - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 180 Pages
  • Global
From
Metastatic Breast Cancer - Pipeline Insight, 2024 - Product Thumbnail Image

Metastatic Breast Cancer - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 100 Pages
  • Global
From
Chagas Disease (American Trypanosomiasis) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Chagas Disease (American Trypanosomiasis) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • July 2022
  • 78 Pages
  • Global
From
Pediatric Neuroblastoma Treatment Global Market Report 2024 - Product Thumbnail Image

Pediatric Neuroblastoma Treatment Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
Glioma Treatment Global Market Report 2024 - Product Thumbnail Image

Glioma Treatment Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
Lung Cancer Drugs Global Market Report 2024 - Product Thumbnail Image

Lung Cancer Drugs Global Market Report 2024

  • Report
  • November 2023
  • 175 Pages
  • Global
From
Crohn's Disease (Regional Enteritis) - Pipeline Review, H2 2020 - Product Thumbnail Image

Crohn's Disease (Regional Enteritis) - Pipeline Review, H2 2020

  • Drug Pipelines
  • August 2020
  • 693 Pages
  • Global
From
Insomnia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Insomnia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • September 2022
  • 109 Pages
  • Global
From
Amyotrophic Lateral Sclerosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Amyotrophic Lateral Sclerosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • September 2022
  • 672 Pages
  • Global
From
Parkinson's Disease Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Parkinson's Disease Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • September 2022
  • 1079 Pages
  • Global
From
The Vaccine Adjuvants Market by Type of Vaccine Adjuvant, Route of Administration, Target Therapeutic Area and Key Geographies: Industry Trends and Global Forecasts, 2022-2035 - Product Thumbnail Image

The Vaccine Adjuvants Market by Type of Vaccine Adjuvant, Route of Administration, Target Therapeutic Area and Key Geographies: Industry Trends and Global Forecasts, 2022-2035

  • Report
  • May 2022
  • 231 Pages
  • Global
From
Malignant Glioma - Pipeline Insight, 2024 - Product Thumbnail Image

Malignant Glioma - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Ewing Sarcoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Ewing Sarcoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • October 2022
  • 204 Pages
  • Global
From
Loading Indicator